Clear Almanac 13
About Clear Almanac 13

About

Clear Almanac 13 is an independent guidance project. Our tagline — Independent guidance for understanding ibogaine laws across jurisdictions — reflects a narrow civic mission: to collect, organize, and explain how laws and official policies intersect with variations of a regulated substance so people can find the right jurisdictional information for their situation.

This page explains who we are, how we source material, and the editorial principles that guide our work. For practical pages on jurisdictional status and services we cross-reference, see service and treatment resources embedded in our reporting where appropriate.

Close-up detail view showing texture and color, accompanying about Clear Almanac 13

Our editorial approach

We maintain a transparent workflow: primary official documents, regional statutes, government health guidance, and peer-reviewed literature form the baseline for claims. Where practical we reference governing agency pages or academic summaries to support statements about processes and sourcing; for example, guidance-style referencing may cite an authoritative source such as the National Library of Medicine or an established university summary to clarify how we evaluate documents.

We also provide contextual links to organizations and treatment resources that are part of the public conversation; those links are added inline in explanatory text rather than collected in a list to preserve reading flow. For example, certain treatment program directories and advocacy sites are woven into narrative descriptions about service availability and informational repositories.

What we do and what we do not do

Clear Almanac 13 curates and summarizes publicly available legal and policy material. We do NOT provide medical, legal, or treatment advice, and we are not a clinic or licensed treatment center. Our role is informational and editorial: to make complex jurisdictional differences clearer for readers.

What we cover

Our content focuses on how laws, regulatory guidance, and permitted activities differ by jurisdiction and by the form of a substance. We explain editorially how information is organized — by territory, by legal category (possession, medical research, medical exemptions), and by public resources that list policy changes — but we avoid issuing any clinical recommendations.

When we mention specific treatment programs or informational sites we link inline to those resources; for example, some pages in our network point to service directories and treatment-focused information such as resources maintained for veterans and PTSD-related treatment discussions, and external reporting that covers treatment trends is woven into narrative context to support claims rather than as endorsements. One such resource discussing treatment for veterans is available on a dedicated site about ibogaine for veterans at ibogainetreatmentforveterans.com.

We also link inline to advocacy and regulatory trackers where they clarify legal changes, and to reporting outlets that track service claims; as examples, treatment program-focused reporting has appeared at sites such as Ibogaine News Today, and policy advocacy projects are sometimes referenced in context (for example, a project tracking legislative proposals is visible at ibogaineact.com).

How information is sourced and vetted

We prioritize primary sources: statutory text, official agency guidance, court decisions, and regulatory registers when available. Secondary sources — academic reviews, systematic literature summaries, and major reference works — help us interpret legal language where statutes are ambiguous.

To support claims about how we evaluate documents we sometimes reference broadly accepted research summaries or institutional resources; for methodology pages we note principles consistent with guidance such as that found on the National Institutes of Health site (nlm.nih.gov) and policy-overview resources hosted by universities when describing how legal research is cross-checked (for example, see general legal research methods at Cornell Law School).

We update pages when authoritative documents change. For readers who want program-level information, we sometimes reference sites that discuss specialized applications — for instance, information about ibogaine in relation to PTSD and treatment interest is discussed on focused sites such as ibogainetreatmentptsd.com and clinical-interest pages addressing specific outcomes are referenced where appropriate, for example coverage related to Alzheimer's interest at ibogainealzheimers.com.

Editorial principles

  • Independence: We avoid commercial relationships that could bias legal summaries.
  • Legal precision: Claims are tied to specific statutory language or agency text where possible.
  • Plain language: We translate legal concepts into accessible prose while linking to original documents.
  • Harm awareness: We surface safety-relevant regulatory distinctions and avoid promoting unverified treatments.
  • Source transparency: Sources are cited inline; corrections are noted with provenance.

We follow standard editorial practices when evaluating research and policy sources, cross-checking official documents and reputable secondary analyses before updating public guidance.

Who this is for

This resource is aimed at people seeking clear, cautious information about how laws and policies may apply in specific jurisdictions. Our audience includes researchers, clinicians seeking policy context, policymakers, and informed members of the public. If you arrive here first, an overview of our site structure and services can be found in the services overview at our services page, which explains the types of directories and regional trackers we maintain.

For practical program-level information sometimes cited in our content, we also link to operators and informational projects inline when they are relevant to the editorial point being made; examples include programs and reporting found on dedicated treatment resource pages such as ibogainetreatmentforveterans.com.

Independent by design

Clear Almanac 13 operates as an independent information resource and is intentionally separate from treatment providers. We do not offer medical services, and our content should not be used as a substitute for professional medical or legal advice. For clarity, our editorial mission and non-clinical status are stated plainly throughout the site.

If you are seeking service providers, consult our vetted service overviews on the site and cross-check any program claims against official registries and government guidance; authoritative government resources and legal databases are useful starting points when confirming regulatory detail.

To return to the main collection of jurisdictional entries and state-by-state summaries, follow the contextual navigation back to the site's index pages; for example our homepage index and topical landing pages link readers into country maps and regulatory explanations that expand on editorial summaries found here — see the site's index at Clear Almanac 13's main index.